Published: November 10, 2010
Amyris Enters Into Collaboration and Joint Development Agreement with Firmenich
EMERYVILLE, Calif. - (BUSINESS WIRE) - Amyris, Inc. (NASDAQ: AMRS) announced today that it has entered into a
collaboration and joint development agreement with Firmenich, the
largest privately-owned fragrance and flavor company, based in Geneva,
Switzerland. This is the first agreement for Amyris in the fragrance and
flavor industry and provides an opportunity to add higher-value
ingredients to our expanding product portfolio. Under the agreement,
Firmenich will fund technical development at Amyris to produce a
sustainable, cost-effective and reliable source of a key ingredient for
the fragrance and flavor market. Under the agreement, Amyris will
manufacture and supply product to Firmenich, Firmenich will market and
distribute the product, and the parties will share in the economic value
derived. The agreement between the parties also grants worldwide
exclusive commercialization rights in fragrance and flavor to Firmenich
for the ingredient, which will be manufactured by Amyris. In addition,
Firmenich has an option to collaborate with Amyris to develop a second
ingredient.
"The fragrance and flavor market offers a significant additional
opportunity for growth in our renewable chemicals business," said John
Melo, CEO of Amyris. "We are excited to be partnering with Firmenich as
we apply our technology to produce an expanded range of No Compromise
molecules."
"This collaboration with Amyris demonstrates our commitment to
innovation and sustainability. As an industry leader in research and
innovation, we seek and capture breakthrough ideas from around the
world," said Patrick Firmenich, CEO of Firmenich. "Amyris's technology
platform offers great potential to be a key source for sustainable and
high-quality ingredients used in the fragrance and flavor market."
Amyris's synthetic biology platform creates living factories to produce
specific, targeted molecules. Amyris's technology platform may be
applied to produce an array of ingredients currently used in the
fragrance and flavor industry. Amyris designs its No Compromise products
to provide high-quality solutions from sustainable and reliable sources
and at competitive prices. To date, Amyris has focused its technical and
commercial efforts on Biofene (Amyris-produced farnesene) and its
related derivatives. This initiative expands the company's business
beyond Biofene and demonstrates the flexibility of Amyris's platform
technology.
About Amyris
Amyris is building an integrated renewable products company by applying
industrial synthetic biology to genetically modify microorganisms to
serve as living factories. Amyris designs these microorganisms to
produce defined molecules for use as renewable chemicals and
transportation fuels. Amyris Brasil S.A., a subsidiary of Amyris,
oversees the establishment and expansion of Amyris's production in
Brazil, including SMA Indústria QuÃmica S.A., its joint venture with São
Martinho. In addition, Amyris is building fuels distribution
capabilities in the United States through its subsidiary, Amyris Fuels
LLC. More information about Amyris and its subsidiaries is available at www.amyris.com.
About Firmenich
Firmenich is the world's largest privately-owned company (no. 2
worldwide) in the fragrance and flavor business. Founded in Geneva,
Switzerland, in 1895, it has created many of the world's best-known
perfumes and flavors that we enjoy each day. Its passion for smell and
taste is at the heart of its success. Firmenich is renowned for its
creativity and innovation, as well as its exceptional understanding of
consumer trends. Each year, it invests around 10% of its turnover in
R&D, reflecting its continuous desire to understand, share and sublimate
the best that nature has to offer. More information about Firmenich is
available at www.firmenich.com.
Forward-Looking Statements
This release contains forward-looking statements, and any statements
other than statements of historical facts could be deemed to be
forward-looking statements. These forward-looking statements include,
among other things, statements regarding future events (such as
statements regarding Amyris's expectations for its prospects in its
renewable chemicals business) that involve risks and uncertainties.
These statements are based on management's current expectations and
actual results and future events may differ materially due to risks and
uncertainties, including those associated with any delays in production
and commercialization of products and other risks detailed in the "Risk
Factors" section of Amyris's final prospectus for its initial public
offering, as filed on September 28, 2010 pursuant to Rule 424(b) under
the Securities Act of 1933, and its quarterly report on Form 10-Q filed
on November 10, 2010. Amyris disclaims any obligation to update
information contained in these forward-looking statements whether as a
result of new information, future events, or otherwise.
Amyris, Biofene and No Compromise are trademarks or registered
trademarks of Amyris, Inc.
Amyris, Inc.
Erin Kinsella, 510-597-4713
pr@amyris.com
or
Firmenich,
SA
Cathleen Quinn
cathleen.quinn@firmenich.com
Copyright © 2012, Business Wire, Inc., All rights reserved.
Copyright © 2012, NewsBlaze,
Daily News
Search News
